Interim Report Second Quarter 2026

Q2 net sales rose to TSEK 274,625 (from TSEK 210,703), up 30.3% YoY. Gross margin improved to 54.9% (52.0) and EBITDA increased to TSEK 88,660 (from TSEK 68,570), while EBIT was TSEK 61,806 (from TSEK 47,384) with the EBIT margin steady at 22.5%. EPS before dilution climbed to SEK 4.24 (from SEK 3.32), indicating broadly improving profitability on higher revenue.

Analysis

The main read-through is not the revenue growth itself, but that the company is still converting a higher sales base into roughly the same EBITDA/EBIT margin. That implies either reinvestment is ramping faster than operating leverage, or the business is in a phase where pricing/mix gains are being competed away at the opex line. For investors, that matters because the market will likely reward the gross-margin step-up immediately, but a rerating only sticks if next quarter shows SG&A discipline or continued organic demand without extra spend.

Second-order, this kind of print tends to help direct peers with similar mix but weaker execution because it raises the bar for what "good" looks like in the category. It also pressures lower-quality competitors that cannot match both growth and margin resilience, especially if the company is in a niche with low switching costs; however, if the quarter benefited from one-off product mix, favorable FX, or customer timing, the sustainability is limited. Over 1-3 months, the key catalyst is whether management upgrades full-year guidance or confirms order strength; over 6-18 months, the question is whether gross margin gains can be translated into EBIT expansion rather than simply funding faster growth.

Contrarian view: consensus may be too focused on the top-line surprise and not enough on the flat margin stack. That usually signals a "good business, but not yet a great earnings compounding story" profile, and those names often mean-revert when growth normalizes. The thesis would be falsified if the next report shows gross margin rollback, slower organic growth, or no evidence that operating expenses are scaling below revenue; conversely, a second consecutive quarter of margin stability would make this a legitimate quality rerating candidate.

Key Decisions for Investors

• No immediate chase: treat the print as confirmation, not a catalyst, unless the stock sells off 3-5% or more on profit-taking; only add on weakness if the next update confirms organic growth rather than acquisition-led sales.
• Watch for next-quarter guidance and SG&A commentary as the key falsifier; if opex grows faster than sales again, the 1-3 month setup becomes a fade rather than a buy.
• If you need exposure to the theme, prefer a basket approach: long high-quality Nordic small/mid-cap industrials with visible margin expansion, short lower-quality cyclicals that cannot hold gross margin in a similar demand backdrop.
• Set an alert for any guidance reset or order-book deceleration in the next 4-8 weeks; that would cap multiple expansion and make the current quarter look like a one-off mix benefit.
• If the company is liquid enough for event-driven trading, consider selling a post-earnings pop via call overwrites rather than outright shorting; the risk/reward is better if the market is already paying for a quality re-rating.